Buy Retatrutide 40mg (R&D Only)
Retatrutide 40mg is a high-purity research peptide formulated exclusively for scientific research and laboratory applications. Developed as a cutting-edge triple receptor agonist, Retatrutide simultaneously targets GLP-1, GIP and glucagon receptors, providing researchers with an innovative tool for exploring complex metabolic and endocrine signalling pathways.
As one of the most significant advancements in modern peptide science, Retatrutide continues to attract substantial interest from researchers studying metabolic regulation, receptor interactions, peptide pharmacology and endocrine biology. Its unique receptor profile makes it a valuable compound for advanced scientific investigations.
What Is Retatrutide?
Retatrutide is a synthetic peptide engineered to activate three key receptor systems involved in biological signalling and metabolic communication:
- GLP-1 (Glucagon-Like Peptide-1) Receptors
- GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptors
- Glucagon Receptors
This triple-agonist mechanism allows researchers to investigate multiple biological pathways simultaneously, making Retatrutide one of the most versatile compounds available for peptide research.
Its advanced molecular structure continues to position Retatrutide at the forefront of next-generation metabolic research.
Key Features
High-Purity 40mg Formula
Each vial contains:
- 40mg Retatrutide
- Research Grade Quality
- High-Purity Peptide Content
- Lyophilised Powder Format
The higher 40mg concentration is ideal for extensive research protocols and advanced laboratory projects.
Triple Receptor Agonist
Retatrutide simultaneously interacts with:
- GLP-1 Receptors
- GIP Receptors
- Glucagon Receptors
This unique receptor activity provides researchers with opportunities to study interconnected signalling pathways within a single model.
Research Grade Manufacturing
Manufactured under stringent quality-control standards to ensure purity, consistency and laboratory reliability.
Suitable for Advanced Research
Frequently utilised in:
- Metabolic pathway studies
- Receptor pharmacology
- Endocrine investigations
- Peptide development
- Stability testing
- Formulation optimisation
Research Applications
Metabolic Research
Retatrutide is commonly investigated in studies examining metabolic regulation, signalling pathways and receptor-mediated biological responses.
GLP-1 Receptor Studies
Researchers utilise Retatrutide to evaluate receptor activation mechanisms and downstream signalling processes associated with GLP-1 pathways.
GIP Research
The peptide is frequently used in investigations involving GIP receptor activity and biological communication systems.
Glucagon Receptor Investigations
Retatrutide’s glucagon receptor activity provides valuable opportunities to study complex endocrine and metabolic interactions.
Peptide Pharmacology
Suitable for studies involving:
- Receptor-binding analysis
- Biological activity evaluation
- Pharmacodynamic investigations
- Stability assessments
Formulation Development
Researchers often utilise Retatrutide in projects involving:
- Delivery system research
- Compound optimisation
- Stability testing
- Research product development
Why Choose Retatrutide 40mg?
Advanced Triple Agonist Technology
Retatrutide is regarded as one of the most sophisticated peptide compounds currently available for scientific research.
Significant Scientific Interest
Its unique ability to activate GLP-1, GIP and glucagon receptors simultaneously has generated widespread interest throughout the scientific community.
Premium Research Quality
Produced according to rigorous standards to support reproducible laboratory outcomes and research consistency.
Broad Scientific Applications
Suitable across multiple disciplines including:
- Metabolic biology
- Endocrinology
- Receptor science
- Peptide pharmacology
- Cellular signalling
- Drug development research
Storage Information
For optimal stability:
- Store refrigerated at 2°C–8°C
- Protect from direct sunlight
- Avoid excessive heat exposure
- Keep vial tightly sealed
- Follow laboratory handling protocols
Proper storage helps preserve peptide integrity and maintain research quality.
Important Disclaimer
This product is supplied strictly for Research & Development purposes only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of disease. All handling should be conducted by qualified professionals in controlled laboratory environments.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Retatrutide 40mg |
| Active Ingredient | Retatrutide |
| Strength | 40mg |
| Format | Lyophilised Powder |
| Category | Triple Agonist Research Peptide |
| Targets | GLP-1, GIP & Glucagon Receptors |
| Grade | Research Grade |
| Storage | 2°C–8°C |
| Application | Research Use Only |
Frequently Asked Questions
What is Retatrutide 40mg?
Retatrutide 40mg is a research-grade triple agonist peptide developed for laboratory investigations involving GLP-1, GIP and glucagon receptor pathways.
Why is Retatrutide considered a triple agonist?
Retatrutide simultaneously activates GLP-1, GIP and glucagon receptors, allowing researchers to investigate multiple signalling systems within a single compound.
What research areas commonly use Retatrutide?
Researchers frequently utilise Retatrutide in metabolic studies, endocrine research, receptor pharmacology, peptide science and formulation development.
What format is Retatrutide supplied in?
The product is supplied as a high-purity lyophilised peptide powder suitable for laboratory applications.
How should Retatrutide be stored?
Store refrigerated between 2°C and 8°C while protecting the product from heat, moisture and direct sunlight.
Is Retatrutide intended for human use?
No. This product is supplied exclusively for research and development purposes.




Reviews
There are no reviews yet.